functional service provider (FSP)

Functional Services Provider (FSP) Banner

Custom-Tailored Approach

At ProPharma, we offer a unique approach to the traditional Clinical Research Organization (CRO) Full-Service Provider (FSP) model. As the world’s largest Research Consulting Organization (RCO), we provide tailored and customized FSP solutions designed to fit your precise needs. Our offerings are both cost-effective and quality-focused, ensuring that you receive the maximum value for your investment.

ProPharma offers a range of FSP models that can accommodate various requirements, providing specific therapeutic area expertise, operational expertise, and integrated processes and systems. Our primary goal is to identify the most appropriate outsourcing approach for your project, ensuring a perfect fit for your needs. Our expertise spans across clinical operations, clinical data sciences, biostatistics, safety, nonclinical, and medical writing, enabling us to assist our clients in developing comprehensive FSP solutions.

In addition, when outsourcing a cohesive book of studies for full-service support, ProPharma can provide a hybrid FSP/FSO (Full Service Outsourcing) approach that provides the best of both worlds: end-to-end clinical study support that utilizes dedicated resources to ensure consistency and transferability of knowledge from one study to the next. With this model, you can have confidence that each study is approached with the same level of expertise and gain efficiencies through increased compound knowledge.

FSP Resourcing Solutions

The global shortage of resources is a crisis that impacts the entire pharmaceutical industry. Finding experienced talent has become increasingly challenging and expensive. Utilizing smart recruitment strategies that leverage both our clinical recruitment team and the resources of Planet Pharma, our access to talent is unparalleled. Whether you need to outsource an entire function or establish a small, focused team for a specific area, we can find you the best-in-class expertise to develop an FSP where others fail.

Portfolio Management with FSP

Accurately forecasting resourcing needs is always a challenge within the clinical trial domain. With over 20 years of experience in developing FSP solutions, ProPharma understands the need to make nimble adjustments as queries and responses from regulatory bodies frequently impact clinical timelines. As more than just a staff augmentation provider, ProPharma can help you in efficiently managing your portfolio of work and partner with your leadership to adjust your resource strategies as needed.

Partner with us!

Customized FSP Strategy. Globally Scaled Solutions.

A thoughtfully designed and custom tailored solution for your FSP needs.

Single or Multi-Functional Solution

We offer FSP solutions in a variety of functional areas including: 

Robust Quality Oversight

ProPharma's FSP solutions include complete ownership of the quality of work in support of clinical trials with multiple touchpoints for issue escalation including:

  • Executive Leadership Oversight
  • Governance Structure
  • Joint Operating Committees (JOC) for multi-functional engagements
  • Functional Governance Committees
  • Operational Leadership
  • Customized quality metrics with convenient read-outs provided in the form of dashboards or PowerPoint presentations
  • Support from the ProPharma Quality Team

Flexible Billing Models

We can tailor an FSP solution to fix the needs of any scope of work, including: 

  • FTE fixed monthly rates
  • Time & Material
  • Unit-based Pricing
  • Hybrid models of any of the above 
Thumbnail Image for Reimagining FSP with ProPharma’s RCO Model

Exceptional Quality

By monitoring key metrics, checking for variations, evaluating enforcement trends, and investing in industry-leading expertise, we become your partner in achieving measurable results. When you work with us, you gain access to a high-caliber team that analyzes your KPIs to optimize your existing operational environment and develops tailor-made solutions that fill the gaps to create exceptional results.

Therapeutic Expertise

Our global team consists of Subject Matter Experts (SMEs) with diverse backgrounds across the pharmaceutical, biotechnology, medical device, and diagnostic industries. With our deep-rooted expertise across countless therapeutic areas, we can anticipate obstacles and develop strategies that fit our clients’ unique needs. Having a top-tier team of professionals allows our FSP infrastructure to move resources internally across clinical programs.

Time and Cost Efficiencies

The FSP model offers significant reduction in costs with greater potential to drive operational efficiencies over time. We enable companies to grow in infrastructure without the headcount burden & risks associated with HR costs & processes. Let ProPharma manage the administrative burden, so you can concentrate on the core tasks of the clinical trial, ensuring business continuity and driving efficiency.

100% Dedicated Teams

We not only provide FSP solutions but we also tailor them to your needs by engaging experts who are experienced across all phases of clinical development. At ProPharma, we know that a successful compound starts with assembling the right team, and we’ll build it with you. Our FSP model is a win-win functional solution because it fosters a partnership that brings together shared expertise & industry experience.



ProPharma as your preferred Functional Service Provider (FSP)

At ProPharma, FSPs are true functional partnerships – we become an extension of your team, fully dedicated to the delivery of your clinical portfolio. With our FSP solutions, you will benefit from:

Reduced administration burden

Consistency of support

Continual monitoring of robust KPIs and metrics.

Cost Savings

Scalable FSP Model for Managing IVD Clinical Trials in a Niche Market

Scaling resources for clinical trials can be a daunting task, especially when demands fluctuate over time. In this case study, a sponsor faced several challenges related to resource allocation and...

FSP models for IVD Clinical Trials: Meeting Growing Pipeline Demands

Streamlining Clinical Trial Operations: How the FSP Model Transformed a Mid-Sized Biotech Company's Success. In this case study, we delve into the experience of a mid-sized genetic testing and...

Functional Service Provider (FSP) Value Proposition

At ProPharma, we forge strategic partnerships with our clients to collaboratively devise optimal strategies and drive remarkable results and operational excellence. With our cutting-edge FSP...

News & Insights

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

PMA Post-Approval Study Considerations

October 7, 2024

PMA Post-Approval Study Considerations

Learn the essential considerations for conducting Post-Approval Studies (PAS) for medical devices, including protocols, timelines, and reporting requirements to ensure compliance with FDA regulations.

What is a Clinical Evaluation Report (CER)?

September 30, 2024

What is a Clinical Evaluation Report (CER)?

Learn the fundamentals of a Clinical Evaluation Report (CER), its evolution under EU MDR, and strategies for ensuring compliance with medical device regulations.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Post Arrow Next Post Arrow
ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

Previous Award Arrow Next Award Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

PMA Post-Approval Study Considerations

October 7, 2024

PMA Post-Approval Study Considerations

Learn the essential considerations for conducting Post-Approval Studies (PAS) for medical devices, including protocols, timelines, and reporting requirements to ensure compliance with FDA regulations.

What is a Clinical Evaluation Report (CER)?

September 30, 2024

What is a Clinical Evaluation Report (CER)?

Learn the fundamentals of a Clinical Evaluation Report (CER), its evolution under EU MDR, and strategies for ensuring compliance with medical device regulations.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow